<html>
<head>
<title>Biofourmis raises $35M to develop smarter treatments for chronic diseases • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">Biofourmis 筹集 3500 万美元开发更智能的慢性病治疗技术 TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2019/05/21/biofourmis-raises-35m/amp/">https://web.archive.org/web/https://techcrunch.com/2019/05/21/biofourmis-raises-35m/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg 2160w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=150,80 150w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=300,160 300w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=768,410 768w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=680,363 680w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=1536,819 1536w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=2048,1092 2048w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=1200,640 1200w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=50,27 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/5953312266b2cc56df7201725222ce05.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg 2160w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=150,80 150w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=300,160 300w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=768,410 768w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=680,363 680w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=1536,819 1536w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=2048,1092 2048w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=1200,640 1200w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?resize=50,27 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/cardiac.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong>krisanapong detraphiphat/Getty Images(图片已修改)</p><p class="translated"><a href="https://web.archive.org/web/20230128055614/https://www.biofourmis.com/"> Biofourmis </a>是一家总部位于新加坡的初创公司，开创了一种独特的基于技术的慢性病治疗方法，已经筹集了 3500 万美元的 B 轮融资用于扩张。</p>
<p class="translated">这轮融资由红杉印度(Sequoia India)和 MassMutual Ventures 领投，mass Mutual Ventures 是马萨诸塞州互惠人寿保险公司(Mutual Life Insurance Company)的风险投资基金。其他投资者包括新加坡经济发展局的企业投资部门 EDBI、中国医疗保健平台建科以及现有投资者 Openspace Ventures、Aviva Ventures 和新加坡政府为深度科技初创公司发起的 SGInnovate。根据 Crunchbase 的消息，<a href="https://web.archive.org/web/20230128055614/https://www.crunchbase.com/organization/biofourmis-pte-ltd#section-overview">这一轮 Biofourmis 到目前为止已经筹集了 4160 万美元。</a></p>
<p class="translated">这不是典型的 TechCrunch 融资故事。</p>
<p class="translated">Biofourmis 首席执行官库尔迪普·辛格·拉吉普特(Kuldeep Singh Rajput)搬到新加坡攻读博士学位，但他在 2015 年辍学，与联合创始人文都·牛(音译)一起创业，因为他看到了“在疾病发生前预测疾病”的潜力，他在接受 TechCrunch 采访时表示。</p>
<h2 class="translated">人工智能驱动的专家出院后护理</h2>
<p class="translated">Biofourmis 的工作有许多层面，但本质上它使用从患者收集的数据和基于人工智能的系统的组合，为出院后的患者定制治疗。该公司专注于一系列治疗方法，但其最先进的是心脏治疗，因此在心力衰竭或其他心脏相关疾病后出院的患者。</p>
<p class="translated">对于这部分患者，Biofourmis 平台使用来自传感器的数据(医疗传感器，而不是全天候佩戴的消费者可穿戴设备)及其技术来监控患者健康，提前检测问题，并制定最佳治疗方案。这些信息通过配套的移动应用程序传播给病人和护理人员。</p>
<p/><div id="attachment_1830769" class="wp-caption aligncenter amp-wp-e7c3b8e" data-amp-original-style="width: 3311px"><amp-img aria-describedby="caption-attachment-1830769" class="wp-image-1830769 size-full amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" src="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png" alt="" srcset="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png 3301w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=150,86 150w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=300,171 300w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=768,439 768w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=680,389 680w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=1536,878 1536w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=2048,1171 2048w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=1200,686 1200w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=50,29 50w" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img aria-describedby="caption-attachment-1830769" decoding="async" loading="lazy" class="wp-image-1830769 size-full" src="../Images/122f536a47bbb579be285d58cd5b8f38.png" alt="" srcset="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png 3301w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=150,86 150w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=300,171 300w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=768,439 768w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=680,389 680w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=1536,878 1536w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=2048,1171 2048w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=1200,686 1200w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png?resize=50,29 50w" sizes="(max-width: 3301px) 100vw, 3301px" data-original-src="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/BiovitalsHF1.png"/></noscript></amp-img><p id="caption-attachment-1830769" class="wp-caption-text translated">Biofourmis 使用移动应用程序作为接触点，在患者出院后为他们提供量身定制的护理和药物处方</p></div>
<p class="translated">也就是说，药物对不同的人有不同的作用，因此通过收集和监测数据并处理数据，Biofourmis 可以提供最好的药物，通过它所谓的“数字药丸”来帮助优化患者的健康。这不是矩阵风格的未来学，它更像是一个基于病人需求实时发展的数字处方。它计划利用一个医疗交付平台网络，包括亚马逊拥有的 PillPack，在几小时内将药物送到患者手中。</p>
<p class="translated">是的，那是将来时，因为 Biofourmis 正在等待 FDA 批准将其服务商业化。Singh Rajput 告诉 TechCrunch，预计这将在今年年底实现。但他很乐观，因为临床试验已经覆盖了 20 个不同地点的约 5000 名患者。</p>
<p class="translated">在技术方面，Singh Rajput 表示，Biofourmis 的预测已经取得了令人印象深刻的结果。他引用了美国的测试，该测试使该公司能够“提前 14 天预测心力衰竭”，灵敏度约为 90%。这是通过使用标准的医疗可穿戴设备实现的，价格为数百美元，而不是数千美元，配备了先进的套件，如波士顿科学的<a href="https://web.archive.org/web/20230128055614/http://www.bostonscientific.com/content/gwc/en-US/medical-specialties/electrophysiology/heartlogic-heart-failure-diagnostic.html">heart logic——尽管后者的预测窗口更长。</a></p>
<p class="translated">Biofourmis 的这种破坏可能会扰乱制药公司的苹果车，但 Singh Rajput 坚持认为，该行业正在朝着更定性的医疗保健方法发展，因为很难评估药物的性能并相应地定价。</p>
<p class="translated">“今天，保险公司在如何给药物定价上缺乏透明度，这让他们很盲目，”他说。“但市场上已经有<span data-amp-original-style="font-size: 1.125rem; letter-spacing: -0.1px;" class="amp-wp-c53f4e1"> 50 种药物根据结果付费，所以市场正在向那个方向发展。”</span></p>
<p class="translated">基于结果的支付意味着保险公司根据药物的表现来补偿所有的结果；换句话说，病人恢复得有多好。费率各不相同，但缓解率没有降低可能会导致保险公司降低支出，因为药物的效果不如预期。</p>
<p class="translated">Singh Rajput 认为 Biofourmis 可以平衡竞争环境，并在药物性能方面增加更多的透明度。他认为制药公司热衷于展示他们的产品比其他产品表现更好，所以从长远来看，这是 Biofourmis 希望鼓励的模式。</p>
<p class="translated">事实上，这种信心是如此之大，Biofourmis 打算首先通过制药公司进入市场，制药公司将把这种包装与他们的药物捆绑在一起出售给诊所，然后一旦获得牵引力，就与保险公司合作。虽然 Biofourmis 可能会与初始药物捆绑销售，但该公司将从通过其数字药丸销售的推荐药物中收取 5-10%的佣金。</p>
<p/><div id="attachment_1830772" class="wp-caption aligncenter amp-wp-26a4ecb" data-amp-original-style="width: 1033px"><amp-img aria-describedby="caption-attachment-1830772" class="wp-image-1830772 size-full amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" src="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg" alt="" srcset="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg 1023w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=150,87 150w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=300,173 300w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=768,444 768w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=680,393 680w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=50,29 50w" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img aria-describedby="caption-attachment-1830772" decoding="async" loading="lazy" class="wp-image-1830772 size-full" src="../Images/d4343dbe4e795acd73d41432f8956c9c.png" alt="" srcset="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg 1023w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=150,87 150w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=300,173 300w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=768,444 768w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=680,393 680w, https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg?resize=50,29 50w" sizes="(max-width: 1023px) 100vw, 1023px" data-original-src="https://web.archive.org/web/20230128055614im_/https://techcrunch.com/wp-content/uploads/2019/05/Kuldeep2.jpg"/></noscript></amp-img><p id="caption-attachment-1830772" class="wp-caption-text translated">Biofourmis 首席执行官兼联合创始人库尔迪普·辛格·拉吉普特(Kuldeep Singh Rajput)于 2015 年退学，创办了这家公司</p></div>
<h2 class="translated">加倍下注美国。</h2>
<p class="translated">有了这笔新资金，Biofourmis 将把总部迁至波士顿，在即将到来的商业化上加倍努力。它将保留在新加坡的业务，那里有 45 名员工负责软件和产品开发，但新的美国办公室预计将从目前的 14 名员工增加到今年年底的 120 名。</p>
<p class="translated">“从第一天起，美国就一直是主要的市场焦点，”辛格·拉吉普特说。“更接近客户并吸引临床数据科学人才至关重要。”</p>
<p class="translated">虽然他称赞了新加坡，并表示该公司仍致力于新加坡——将 EDBI 纳入其投资者无疑是一个迹象——但他承认，他曾经学习过的波士顿是寻找“<span data-amp-original-style="font-size: 1.125rem; letter-spacing: -0.1px;" class="amp-wp-c53f4e1">具有核心临床能力的数据科学家”的关键市场</span></p>
<p class="translated">这一扩张不仅是为了将有氧运动产品推向市场，也是为了准备涵盖其他疗法的产品。目前，它有六项试验，涵盖疼痛、骨科和肿瘤学。该公司还计划在美国以外的其他市场扩张，尤其是新加坡和中国，Biofourmis 计划在这两个市场领先健科。</p>
<p class="translated">Singh Rajput 信心满满地告诉 TechCrunch，该公司下一次融资时将达到 10 亿美元的估值——估计还有 18 个月，该公司没有透露今天的价值。</p>
<p class="translated">然而，辛格·拉吉普特证实，这轮融资被严重超额认购，这家初创公司拒绝了制药公司的投资提议，以“避免利益冲突并保持中立”。</p>
<p class="translated">他还着眼于未来的首次公开募股，暂定为 2023 年——尽管辛格·拉吉普特说，到那时，Biofourmis 在市场上至少需要两种产品。</p>
<p class="translated">在那之前还有很长的路要走，但这一轮无疑让 Biofourmis 及其数字药丸方法在科技行业中崭露头角。</p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20230128055614im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
	<amp-pixel src="https://web.archive.org/web/20230128055614im_/https://pixel.wp.com/g.gif?v=ext&amp;blog=136296444&amp;post=1830718&amp;tz=-8&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>